Grabner Günther, Ang Robert Edward, Vilupuru Srividhya
Department of Ophthalmology, Paracelsus Medical University, Salzburg, Austria.
Asian Eye Institute, Makati City, Philippines.
Am J Ophthalmol. 2015 Dec;160(6):1176-1184.e1. doi: 10.1016/j.ajo.2015.08.017. Epub 2015 Aug 20.
To evaluate visual performance of subjects implanted monocularly with a small-aperture hydrophobic intraocular lens (IC-8 IOL).
A prospective, noncomparative, multicenter case series.
A series of 12 patients, presenting for cataract surgery, were implanted monocularly with a single-piece hydrophobic acrylic intraocular with a centrally located opaque annular mask measuring 3.23 mm in total diameter with a 1.36 mm central aperture. Uncorrected distance, intermediate, and near visual acuities (UDVA, UIVA, and UNVA); depth of focus; and subjective symptoms were evaluated for 12 months after implantation. Mean ± standard deviation visual acuity is reported in logMAR.
The mean monocular UDVA, UIVA, and UNVA improved significantly from 0.42 ± 0.18, 0.52 ± 0.22 and 0.66 ± 0.23 preoperatively to 0.06 ± 0.08 (P < .0001), 0.07 ± 0.11 (P < .0001), and 0.11 ± 0.15 (P < .0001) at 1 month, respectively, and remained stable until 12 months. At 12 months, 100%, 100%, and 92% of patients achieved 20/32 or better binocularly for UDVA, UIVA, and UNVA, respectively. One hundred percent of eyes maintained 20/40 or better visual acuity over a range of +0.50 diopter to -1.50 diopters of defocus. Subjects implanted with the IC-8 IOL perceived a small magnitude of visual symptoms and rated their symptoms on the lower end of the severity scale.
Early results demonstrate that monocular IC-8 intraocular lens implantation provides a continuous, broad range of vision and excellent acuity across all focal distances.
评估单眼植入小孔径疏水型人工晶状体(IC-8人工晶状体)患者的视觉表现。
一项前瞻性、非对照、多中心病例系列研究。
选取12例拟行白内障手术的患者,单眼植入一体式疏水丙烯酸酯人工晶状体,其中心有一个不透明环形遮挡,总直径为3.23毫米,中心孔径为1.36毫米。在植入后12个月内评估未矫正的远、中、近视力(UDVA、UIVA和UNVA)、焦深和主观症状。视力以logMAR表示,报告平均值±标准差。
单眼平均UDVA、UIVA和UNVA从术前的0.42±0.18、0.52±0.22和0.66±0.23分别显著提高到术后1个月时的0.06±0.08(P<.0001)、0.07±0.11(P<.0001)和0.11±0.15(P<.0001),并一直稳定到12个月。在12个月时,分别有100%、100%和92%的患者双眼UDVA、UIVA和UNVA达到20/32或更好。100%的眼睛在+0.50屈光度至-1.50屈光度的散焦范围内保持20/40或更好的视力。植入IC-8人工晶状体的患者感觉到的视觉症状较轻,症状严重程度评分较低。
早期结果表明,单眼植入IC-8人工晶状体可提供连续、广泛的视力,且在所有焦距下视力均极佳。